HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists

FDA Faces Pressure Over Aduhelm Approval

A US congressional report released this week noted that the Food and Drug Administration (FDA) failed to heed its own advice when approving Aduhelm, a controversial treatment for Alzheimer’s disease. The report blamed the agency for overlooking key issues with data surrounding the drug’s actual […]

more info 12/30/2022View Related Articles
Bookmark and Share

FDA Commissioner Califf Introduces Overdose Prevention Framework

Commissioner Rob Califf discussed the US Food and Drug Administration’s (FDA) approach to the opioid crisis and how the agency will pivot in the near future. In the blog post, he noted that the FDA needs to reevaluate the metrics it uses to study safe usage guidelines for opioids. The agency will […]

more info 08/31/2022View Related Articles
Bookmark and Share

FDA Commissioner Rob Califf Says Agency Will Advance New Evidence Generation System

During a Zoom event on Tuesday, June 12th, Food and Drug Administration (FDA) Commissioner Robert Califf told members of the Alliance for a Stronger FDA that the agency would promote the development of new evidence generation systems. Califf remarked that the US had fallen behind in evidence […]

more info 07/13/2022View Related Articles
Bookmark and Share

Vin Gupta in the Lead for FDA Medical Advisor Role

The US Food and Drug Administration (FDA) is looking for a new principle medical adviser to take charge of public messaging after a series of foibles that have shaken public trust in the agency. Top in the running is Vin Gupta, a pulmonologist who regularly discusses public health on MSNBC and […]

more info 07/06/2022View Related Articles
Bookmark and Share

FDA Gives Amylyx’s ALS Drug a Second Chance

Amylyx’s application for its ALS drug was narrowly shot down by FDA advisors earlier this year because they were not satisfied with the evidence provided. Fortunately for the biotech, the FDA has agreed to discuss the application again on September 7th. According to , “But the move to call […]

more info 07/06/2022View Related Articles
Bookmark and Share

Fagron Group API Facility Receives FDA Warning Over Cleaning Issues

The US Food and Drug Administration (FDA) has issued a warning letter to an active product ingredient (API) facility run by the Netherlands-based Fagron Group. A key accusation was that an employee destroyed cleaning logs, an act deemed more egregious due to the company’s previous issues with the […]

more info 06/30/2022View Related Articles
Bookmark and Share

New FDA Proposal Would Expand Access to Nonprescription Medications

A new proposal by the FDA lays out new requirements to expand the use of a non-prescription drug to additional conditions while maintaining non-prescription status. If the agency finds that a product’s labeling is too unclear, drugmakers can set conditions for non-prescription use instead of making […]

more info 06/28/2022View Related Articles
Bookmark and Share

FDA Will Present Draft Guidance on Real-World Evidence in Grand Rounds on June 22nd

The US Food and Drug Administration will unveil its highly anticipated draft guidance on real-world evidence this Friday, June 24th. The grand rounds session begins at 1:00 PM EST and will be presented by Dr. John Concato. According to Rethinking Clinical Trials, “Dr. Concato is the associate […]

more info 06/22/2022View Related Articles
Bookmark and Share

Breaking: US FDA Approves Moderna and Pfizer’s COVID-19 Vaccines for Children 5 and Under

The US Food and Drug Administration’s (FDA) vaccine advisory committee (Adcomm) voted unanimously (21-0) to approve Moderna and Pfizer’s mRNA-based COVID-19 vaccines for children aged 5 and under. The anticipated approval was urged by many in the healthcare community due to the increasing numbers of […]

more info 06/15/2022View Related Articles
Bookmark and Share

FDA Vocalizes Support for Moderna and Pfizer Vaccines for Children Under 5 One Day Before Advisory Committee

The US Food and Drug Administration (FDA) has signalled support for authorizing the Moderna and Pfizer COVID-19 vaccines for children under the age of 5 just one day before the agency’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is set to meet. The recommended authorization […]

more info 06/13/2022View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 20
  • Next Page

 

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Senior Biostatistician, Statistical Analytics
  • Senior Director, Evidence Synthesis
  • Biostatistical Analyst
  • Sr HEOR Statistician
  • Senior Director, Pharmacoepidemiology and Safety
 
Syndicated Reports

Biotech R&D: a target-rich environment

Global Gene Therapy Report 2022-2031

ePrescribing Market – This is How Key Players are Dominating Global Industry

Health Economics and Outcomes Research (HEOR) Services Market to 2028

 
White Papers

Real World Evidence Solutions Global Market Report 2022

AI for Pharma and Biotech Market Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis and Share by Forecast 2026

Whitepaper – Engaging the End Prescriber: A Practical Guide to Working With Physicians

Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists